Drug
Personalized Vaccine
Personalized Vaccine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_1
3
100%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Withdrawn1
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 13 (100.0%)
Trials by Status
withdrawn133%
completed133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_1
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
NCT03568058
withdrawnphase_1
Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers
NCT05153304
unknownphase_1
Personalized Vaccine for Patients With Recurrent Malignant Glioma
NCT04943718
Clinical Trials (3)
Showing 3 of 3 trials
NCT03568058Phase 1
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
NCT05153304Phase 1
Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers
NCT04943718Phase 1
Personalized Vaccine for Patients With Recurrent Malignant Glioma
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3